Primary Site >> Liver Cancer

Gene >> FGF2

  • 1988
  • 1991
  • 1993
  • 1994
  • 1996
  • 1998
  • 1999
  • 2000
  • 2001
  • 2002
  • 2003
  • 2006
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Production of growth factors related to fibroblast growth factor and platelet-derived growth factor by human embryonal carcinoma cells.
PMID: 3209587
Ref: Characterization of high-molecular-mass forms of basic fibroblast growth factor produced by hepatocellular carcinoma cells: possible involvement of basic fibroblast growth factor in hepatocarcinogenesis.
PMID: 1721615
Ref: Sinusoidal capillarization of human hepatocellular carcinoma: possible promotion by fibroblast growth factor.
PMID: 8388557
Ref: The observation of angiogenin and basic fibroblast growth factor gene expression in human colonic adenocarcinomas, gastric adenocarcinomas, and hepatocellular carcinomas.
PMID: 7513352
Ref: An immunohistochemical study of tumour vessels in metastatic liver cancers and the surrounding liver tissue.
PMID: 8818692
Ref: Tumor cell-conditioned medium stimulates expression of the urokinase receptor in vascular endothelial cells.
PMID: 8908197
Ref: Expression of vascular endothelial growth factor in human hepatocellular carcinoma.
PMID: 9657098
Ref: Establishment and characterization of a new human hepatocellular carcinoma cell line, HAK-3, and its response to growth factors.
PMID: 10493947
Ref: Restriction landmark genomic scanning of mouse liver tumors for gene amplification: overexpression of cyclin A2.
PMID: 10903917
Ref: Mammalian heparanase as mediator of tumor metastasis and angiogenesis.
PMID: 10909416
Ref: Hepatocarcinoma cells stimulate hepatocyte growth factor secretion in human liver myofibroblasts.
PMID: 10995891
Ref: Reciprocal functions of liver tumor cells and endothelial cells. Involvement of endothelial cell migration and tumor cell proliferation at a primary site in distant metastasis.
PMID: 11182622
Ref: [Expression rates of three angiogenic factors in hepatocellular carcinoma and their relation with microvessel density and portal vein tumor thrombosis].
PMID: 11798918
Ref: Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.
PMID: 11915029
Ref: The prognostic molecular markers in hepatocellular carcinoma.
PMID: 12046056
Ref: [Intratumoral microvessel density and expression of vascular endothelial growth factor in hepatocellular carcinoma after chemoembolization].
PMID: 12113668
Ref: Serum endostatin predicts tumor vascularity in hepatocellular carcinoma.
PMID: 12412173
Ref: Recurrence and metastasis of hepatocellular carcinoma: progress and prospects.
PMID: 14607620
Ref: Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.
PMID: 12478660
Ref: [Role of hepatic stellate cells in the angiogenesis of hepatoma].
PMID: 14532719
Ref: Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment.
PMID: 14678990
Ref: [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice].
PMID: 16613672
Ref: [Inhibitory effects of ampelopsin on angiogenesis].
PMID: 16617784
Ref: Cellular changes resulting from forced expression of glypican-3 in hepatocellular carcinoma cells.
PMID: 16682817
Ref: Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis.
PMID: 16929488
Ref: Potential involvement of the cyclooxygenase-2 pathway in hepatocellular carcinoma-associated angiogenesis.
PMID: 17097688
Ref: Hepatic resection but not radiofrequency ablation results in tumor growth and increased growth factor expression.
PMID: 17457170
Ref: Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: a retrospective study.
PMID: 17943391
Ref: Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma.
PMID: 18318435
Ref: The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX.
PMID: 18620777
Ref: [Enhancing effect of antisense oligonucleotide targeting bFGF on apoptosis in hepatoma cells in vitro].
PMID: 18646690
Ref: Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells.
PMID: 18976674
Ref: [Comparison between pathological findings and MR diffusion-weighted imaging in primary hepatocellular carcinoma after transcatheter arterial chemoembolization].
PMID: 19173992
Ref: Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma.
PMID: 19578489
Ref: Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma.
PMID: 19002496
Ref: Pituitary adenoma stem cells.
PMID: 19582428
Ref: [Inhibition of angiogenesis of LCI-D20 hepatocellular carcinoma by metronomic chemotherapy of S-1].
PMID: 19785953
Ref: Significance of serum connective tissue growth factor in patients with hepatocellular carcinoma and relationship with angiogenesis.
PMID: 20512490
Ref: Mechanism of endothelial progenitor cell recruitment into neo-vessels in adjacent non-tumor tissues in hepatocellular carcinoma.
PMID: 20716344
Ref: beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy.
PMID: 20811694
Ref: Synergistic effect of celecoxib on 5-fluorouracil-induced apoptosis in hepatocellular carcinoma patients.
PMID: 21057160
Ref: Hypoxic and highly angiogenic non-tumor tissues surrounding hepatocellular carcinoma: the 'niche' of endothelial progenitor cells.
PMID: 21152281
Ref: [Endothelial genesis inhibitor-8t (EDI-8t) against tumor growth].
PMID: 21387837
Ref: [Autologous bone marrow cell infusion therapy for liver cirrhosis--now and future].
PMID: 22338911
Ref: Chemotherapy with PLGA microspheres containing docetaxel decreases angiogenesis in human hepatoma xenograft.
PMID: 21136211
Ref: Dovitinib demonstrates antitumor and antimetastatic activities in xenograft models of hepatocellular carcinoma.
PMID: 22027573
Ref: Cyclooxygenase-2 and Akt mediate multiple growth-factor-induced epithelial-mesenchymal transition in human hepatocellular carcinoma.
PMID: 22097969
Ref: A novel monoclonal antibody to fibroblast growth factor 2 effectively inhibits growth of hepatocellular carcinoma xenografts.
PMID: 22351746
Ref: Gremlin in the pathogenesis of hepatocellular carcinoma complicating chronic hepatitis C: an immunohistochemical and PCR study of human liver biopsies.
PMID: 22839096
Ref: Total Saponin from Root of Actinidia valvata Dunn Inhibits Hepatoma 22 Growth and Metastasis In Vivo by Suppression Angiogenesis.
PMID: 22956974
Ref: Synthesized multiple antigenic polypeptide vaccine based on B-cell epitopes of human heparanase could elicit a potent antimetastatic effect on human hepatocellular carcinoma in vivo.
PMID: 23308126
Ref: Overexpression of GPC3 inhibits hepatocellular carcinoma cell proliferation and invasion through induction of apoptosis.
PMID: 23338845
Ref: Efficacy, safety, pharmacokinetics, and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: a phase II study.
PMID: 23362324
Ref: Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts.
PMID: 23684136
Ref: Fucoidan inhibits the growth of hepatocellular carcinoma independent of angiogenesis.
PMID: 23737842
Ref: Expression of angiogenic factors in hepatocarcinogenesis: Identification by antibody arrays.
PMID: 23970062
Ref: Cytokines are associated with postembolization fever and survival in hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization.
PMID: 26201926
Ref: Interaction between 8-hydroxyquinoline ruthenium(II) complexes and basic fibroblast growth factors (bFGF): inhibiting angiogenesis and tumor growth through ERK and AKT signaling pathways.
PMID: 24336978
Ref: Pilot study of angiogenic response to yttrium-90 radioembolization with resin microspheres.
PMID: 24360887
Ref: Wnt/beta-catenin signaling pathway may regulate the expression of angiogenic growth factors in hepatocellular carcinoma.
PMID: 24944688
Ref: Sulfatase 1 (hSulf-1) reverses basic fibroblast growth factor-stimulated signaling and inhibits growth of hepatocellular carcinoma in animal model.
PMID: 24970807
Ref: Protein expression under sustained activation of signal transducer and activator of transcription-3 in diethylnitrosamine-induced rat liver carcinogenesis.
PMID: 25009646
Ref: Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma.
PMID: 25275728
Ref: Multiple antigenic polypeptide composed of heparanase Bcell epitopes shrinks human hepatocellular carcinoma in mice.
PMID: 25522727
Ref: Histidine-rich glycoprotein function in hepatocellular carcinoma depends on its N-glycosylation status, and it regulates cell proliferation by inhibiting Erk1/2 phosphorylation.
PMID: 26336134
Ref: Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation.
PMID: 26420968
Ref: Evaluation of neovascularization with spectral computed tomography in a rabbit VX2 liver model: a comparison with real-time contrast-enhanced ultrasound and molecular biological findings.
PMID: 26456032
Ref: The effects of self-assembling peptide RADA16 hydrogel on malignant phenotype of human hepatocellular carcinoma cell.
PMID: 26628972
Ref: MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.
PMID: 26823724
Ref: Correlation between blood circulation grading and angiogenesis using ultrasonic contrast of rabbit VX2 hepatic carcinoma.
PMID: 26919946
Ref: In vitro and in vivo study of hydralazine, a potential anti-angiogenic agent.
PMID: 26968484
Ref: Integrative biomarker analyses indicate etiological variations in hepatocellular carcinoma.
PMID: 27130844
Ref: Hypoxia-inducible factor-1alpha mediates the toll-like receptor 4 signaling pathway leading to anti-tumor effects in human hepatocellular carcinoma cells under hypoxic conditions.
PMID: 27446390
Ref: Insulin-like growth factor-binding protein-3 inhibits IGF-1-induced proliferation of human hepatocellular carcinoma cells by controlling bFGF and PDGF autocrine/paracrine loops.
PMID: 27521890
Ref: TTF1, in the Form of Nanoparticles, Inhibits Angiogenesis, Cell Migration and Cell Invasion In Vitro and In Vivo in Human Hepatoma through STAT3 Regulation.
PMID: 27834930
Ref: Evaluating Tumor-Associated Activity of Extracellular Sulfatase by Analyzing Naturally Occurring Substrate in Tumor Microenvironment of Hepatocellular Carcinoma.
PMID: 28193024
Ref: Plumbagin restrains hepatocellular carcinoma angiogenesis by suppressing the migration and invasion of tumor-derived vascular endothelial cells.
PMID: 28122355
Ref: Synergistic Inhibitory Effect of Traditional Chinese Medicine Astragaloside IV and Curcumin on Tumor Growth and Angiogenesis in an Orthotopic Nude-Mouse Model of Human Hepatocellular Carcinoma.
PMID: 28179291
Ref: Tyrosine Kinase Expressed in Hepatocellular Carcinoma, TEC, Controls Pluripotency and Early Cell Fate Decisions of Human Pluripotent Stem Cells via Regulation of Fibroblast Growth Factor-2 Secretion.
PMID: 28631381
Ref: Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study.
PMID: 29258450
Ref: Efficacy of Ciji Hua'ai Baosheng formula on the expressions of vascular endothelial growth factor, kinase insert domain-containing receptor and basic fibroblast growth factor in mouse models of H(22) hepatocellular carcinoma.
PMID: 29957915
Ref: External Beam Radiation Therapy Enhances Mesenchymal Stem Cell-Mediated Sodium-Iodide Symporter Gene Delivery.
PMID: 29724129
Ref: Antitumor effects of melanin from Lachnum YM226 and its derivative in H22 tumor-bearing mice.
PMID: 30108995